ProShare Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Sell |
14,168
-270
| -2% | -$8.51K | ﹤0.01% | 1182 |
|
|
2025
Q1 | $473K | Sell |
14,438
-3,401
| -19% | -$111K | ﹤0.01% | 1128 |
|
|
2024
Q4 | $645K | Buy |
17,839
+4,008
| +29% | +$145K | ﹤0.01% | 1130 |
|
|
2024
Q3 | $431K | Sell |
13,831
-8,321
| -38% | -$259K | ﹤0.01% | 1223 |
|
|
2024
Q2 | $593K | Buy |
22,152
+8,293
| +60% | +$222K | ﹤0.01% | 890 |
|
|
2024
Q1 | $473K | Buy |
13,859
+1,021
| +8% | +$34.8K | ﹤0.01% | 1123 |
|
|
2023
Q4 | $372K | Buy |
12,838
+1,669
| +15% | +$48.3K | ﹤0.01% | 1238 |
|
|
2023
Q3 | $308K | Sell |
11,169
-170
| -1% | -$4.69K | ﹤0.01% | 1195 |
|
|
2023
Q2 | $341K | Buy |
11,339
+277
| +3% | +$8.33K | ﹤0.01% | 1189 |
|
|
2023
Q1 | $401K | Sell |
11,062
-1,367
| -11% | -$49.5K | ﹤0.01% | 1018 |
|
|
2022
Q4 | $443K | Buy |
12,429
+1,068
| +9% | +$38.1K | ﹤0.01% | 1016 |
|
|
2022
Q3 | $384K | Buy |
11,361
+164
| +1% | +$5.54K | ﹤0.01% | 1013 |
|
|
2022
Q2 | $323K | Sell |
11,197
-5,370
| -32% | -$155K | ﹤0.01% | 1169 |
|
|
2022
Q1 | $536K | Sell |
16,567
-3,295
| -17% | -$107K | ﹤0.01% | 1246 |
|
|
2021
Q4 | $578K | Buy |
19,862
+843
| +4% | +$24.5K | ﹤0.01% | 1351 |
|
|
2021
Q3 | $507K | Sell |
19,019
-4,694
| -20% | -$125K | ﹤0.01% | 1211 |
|
|
2021
Q2 | $730K | Buy |
23,713
+1,822
| +8% | +$56.1K | ﹤0.01% | 1247 |
|
|
2021
Q1 | $573K | Buy |
21,891
+1,944
| +10% | +$50.9K | ﹤0.01% | 1347 |
|
|
2020
Q4 | $502K | Buy |
19,947
+4,529
| +29% | +$114K | ﹤0.01% | 1276 |
|
|
2020
Q3 | $321K | Sell |
15,418
-486
| -3% | -$10.1K | ﹤0.01% | 1139 |
|
|
2020
Q2 | $378K | Buy |
15,904
+4,942
| +45% | +$117K | ﹤0.01% | 1092 |
|
|
2020
Q1 | $197K | Sell |
10,962
-8,504
| -44% | -$153K | ﹤0.01% | 1014 |
|
|
2019
Q4 | $462K | Sell |
19,466
-1,675
| -8% | -$39.8K | ﹤0.01% | 1106 |
|
|
2019
Q3 | $581K | Sell |
21,141
-838
| -4% | -$23K | ﹤0.01% | 927 |
|
|
2019
Q2 | $727K | Sell |
21,979
-2,604
| -11% | -$86.1K | ﹤0.01% | 881 |
|
|
2019
Q1 | $861K | Buy |
24,583
+246
| +1% | +$8.62K | 0.01% | 833 |
|
|
2018
Q4 | $808K | Sell |
24,337
-4,265
| -15% | -$142K | 0.01% | 771 |
|
|
2018
Q3 | $1.44M | Sell |
28,602
-1,286
| -4% | -$64.7K | 0.01% | 680 |
|
|
2018
Q2 | $1.79M | Sell |
29,888
-1,585
| -5% | -$94.9K | 0.01% | 644 |
|
|
2018
Q1 | $1.44M | Sell |
31,473
-4,871
| -13% | -$223K | 0.01% | 696 |
|
|
2017
Q4 | $1.45M | Buy |
36,344
+3,542
| +11% | +$141K | 0.01% | 712 |
|
|
2017
Q3 | $1.31M | Buy |
32,802
+2,055
| +7% | +$82.2K | 0.01% | 670 |
|
|
2017
Q2 | $1.33M | Sell |
30,747
-2,572
| -8% | -$111K | 0.01% | 655 |
|
|
2017
Q1 | $1.04M | Sell |
33,319
-8,025
| -19% | -$251K | 0.01% | 734 |
|
|
2016
Q4 | $1.04M | Buy |
41,344
+3,836
| +10% | +$96.9K | 0.01% | 755 |
|
|
2016
Q3 | $928K | Sell |
37,508
-5,792
| -13% | -$143K | 0.01% | 704 |
|
|
2016
Q2 | $882K | Buy |
43,300
+2,096
| +5% | +$42.7K | 0.01% | 761 |
|
|
2016
Q1 | $628K | Sell |
41,204
-3,992
| -9% | -$60.8K | 0.01% | 899 |
|
|
2015
Q4 | $607K | Buy |
45,196
+4,332
| +11% | +$58.2K | 0.01% | 949 |
|
|
2015
Q3 | $573K | Sell |
40,864
-2,153
| -5% | -$30.2K | 0.01% | 891 |
|
|
2015
Q2 | $730K | Buy |
43,017
+2,774
| +7% | +$47.1K | 0.01% | 920 |
|
|
2015
Q1 | $487K | Buy |
40,243
+5,524
| +16% | +$66.8K | 0.01% | 1185 |
|
|
2014
Q4 | $288K | Buy |
34,719
+973
| +3% | +$8.07K | ﹤0.01% | 1547 |
|
|
2014
Q3 | $293K | Sell |
33,746
-6,051
| -15% | -$52.5K | ﹤0.01% | 1734 |
|
|
2014
Q2 | $436K | Sell |
39,797
-2,581
| -6% | -$28.3K | 0.01% | 1672 |
|
|
2014
Q1 | $379K | Buy |
42,378
+26,327
| +164% | +$235K | ﹤0.01% | 2077 |
|
|
2013
Q4 | $121K | Sell |
16,051
-4,220
| -21% | -$31.8K | ﹤0.01% | 1296 |
|
|
2013
Q3 | $149K | Buy |
+20,271
| New | +$149K | ﹤0.01% | 2296 |
|